KESTRA MEDICAL TECHNOLOGIES LTD (KMTS)

Healthcare | Medical Instruments Supplies
Income Statement (Quarterly) 2025-07-31 2025-01-31 2024-04-30 2024-01-31
Revenue 19,371,000 15,090,000 10,054,000 8,277,000
Cost of Revenue 10,520,000 8,543,000 8,657,000 7,397,000
Gross Profit 8,851,000 6,547,000 1,397,000 880,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 33,728,000 23,795,000 17,925,000 17,091,000
Operating Expenses 37,729,000 27,148,000 21,746,000 20,826,000
Operating Income -28,878,000 -20,601,000 -20,349,000 -19,946,000
Interest Expense 1,912,000 1,783,000 1,935,000 1,651,000
Income Before Tax -25,793,000 -21,741,000 -22,311,000 -21,605,000
Income Tax Expense 33,000 18,000 -27,000 14,000
Net Income -25,826,000 -21,509,000 -22,284,000 -21,619,000
Per Share
EPS -0.50 -0.50 -0.45 -0.47
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-04-30 2024-04-30
Revenue 59,815,000 27,814,000
Cost of Revenue 35,605,000 27,452,000
Gross Profit 24,210,000 362,000
Operating Expenses
R&D Expenses 0 0
SG&A Expenses 114,936,000 69,935,000
Operating Expenses 130,588,000 85,425,000
Operating Income -106,378,000 -85,063,000
Interest Expense 7,734,000 6,230,000
Income Before Tax -113,679,000 -94,096,000
Income Tax Expense 135,000 24,000
Net Income -113,814,000 -94,120,000
Per Share
EPS -5.13 -2.04
EPS Diluted 0.00 0.00
Balance Sheet (Quarterly) 2025-04-30 2024-04-30
Assets
Cash and Cash Equivalents 237,595,000 8,249,000
Short Term Investments 0 0
Net Receivables 8,081,000 1,998,000
Inventory 6,572,000 3,290,000
Total Current Assets 255,328,000 14,907,000
Property Plant Equipment 36,908,000 28,391,000
Goodwill and Intangibles 0 0
Total Assets 295,744,000 45,949,000
Liabilities
Account Payables 23,961,000 23,892,000
Short Term Debt 374,000 0
Total Current Liabilities 37,977,000 32,971,000
Long Term Debt 44,124,000 45,169,000
Total Liabilities 90,338,000 255,326,000
Shareholders Equity
Retained Earnings -520,249,000 -406,435,000
Total Shareholders Equity 205,406,000 -209,377,000
Balance Sheet (Annual) 2025-04-30 2024-04-30
Assets
Cash and Cash Equivalents 237,595,000 8,249,000
Short Term Investments 0 0
Net Receivables 8,081,000 1,998,000
Inventory 6,572,000 3,290,000
Total Current Assets 255,328,000 14,907,000
Property Plant Equipment 36,908,000 28,391,000
Goodwill and Intangibles 0 0
Total Assets 295,744,000 45,949,000
Liabilities
Account Payables 23,961,000 23,892,000
Short Term Debt 374,000 0
Total Current Liabilities 37,977,000 32,971,000
Long Term Debt 44,124,000 45,169,000
Total Liabilities 90,338,000 255,326,000
Shareholders Equity
Retained Earnings -520,249,000 -406,435,000
Total Shareholders Equity 205,406,000 -209,377,000
Cash Flow Statement (Quarterly) 2025-04-30 2024-04-30
Operating Activities
Net Income -113,814,000 -94,120,000
Depreciation & Amortization 7,968,000 11,560,000
Stock Based Compensation 24,270,000 1,488,000
Change in Working Capital -6,203,000 4,388,000
Operating Cash Flow -77,608,000 -72,235,000
Investing Activities
Capital Expenditure -23,591,000 -12,514,000
Investments -23,591,000 -12,514,000
Investing Cash Flow -23,308,000 -12,229,000
Financing Activities
Debt Repayment 0 5,877,000
Common Stock Issued/Repurchased 215,789,000 0
Dividends Paid -1,654,000 -799,000
Financing Cash Flow 330,262,000 77,725,000
Summary
Free Cash Flow -101,199,000 -84,749,000
Net Change in Cash 229,346,000 -6,739,000
Cash Flow Statement (Annual) 2025-04-30 2024-04-30
Operating Activities
Net Income -113,814,000 -94,120,000
Depreciation & Amortization 7,968,000 11,560,000
Stock Based Compensation 24,270,000 1,488,000
Change in Working Capital -6,203,000 4,388,000
Operating Cash Flow -77,608,000 -72,235,000
Investing Activities
Capital Expenditure -23,591,000 -12,514,000
Investments -23,591,000 -12,514,000
Investing Cash Flow -23,308,000 -12,229,000
Financing Activities
Debt Repayment 0 5,877,000
Common Stock Issued/Repurchased 215,789,000 0
Dividends Paid -1,654,000 -799,000
Financing Cash Flow 330,262,000 77,725,000
Summary
Free Cash Flow -101,199,000 -84,749,000
Net Change in Cash 229,346,000 -6,739,000